Toxic oil syndrome: Survival in the whole cohort between 1981 and 1995

Journal of Clinical Epidemiology

Volumn 56, Issue 7, 2003, Pages 701-708

  Valadés, P Sánchez Porro ^a   De La Paz, M Posada ^a   De Andres Copa P ^a   Gimenez Ribota, O ^a   Abaitua Borda, I ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cohort study; Prognostic factors; Survival analysis; Toxic oil syndrome

Indexed keywords

RAPESEED OIL;

AGED; ANALYTIC METHOD; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; HUMAN; LIVER DISEASE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR NEUROPATHY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REGRESSION ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; TOXIC OIL SYNDROME;

EID: 0042561843     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(03)00119-7     Document Type: Article

References (26)

1. Tabuenca J.M. Toxic allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet. 2:1981;567-568.
2. Posada de la Paz M., Philen R.M., Abaitua Borda I. Toxic oil syndrome: the perspective after 20 years. Epidemiol Rev. 23:2001;231-247.
3. Calaf R.E., Pena J., Paytubi S., et al. Determination of aniline derivatives in oils related to the toxic oil syndrome by atmospheric pressure ionization-tandem mass spectrometry. Anal Chem. 73:2001;3828-3837.
4. Posada M., Philen R.M., Abaitua I., et al. Manufacturing processes at two French rapeseed oil companies: possible relationships to toxic oil syndrome in Spain. Food Chem Toxicol. 29:1991;797-803.
5. Toxic oil syndrome: mass food poisoning in Spain. Grandjean P., Tarkowski S. Report of a WHO meeting: Madrid 21 March 1983. 1984;3-9 World Health Organization Regional Office for Europe, Copenhagen.
6. Ministerio de Sanidad y Consumo. Síndrome Tóxico X. Epidemiología: distribución espacial. Boletín Epidemiológico Semanal. 1491:1981;201-203.
7. Abaitua Borda I., Posada de la Paz M. Clinical findings. World Health Organization. Regional Office for Europe. Toxic oil syndrome: current knowledge and future perspectives. 1992;25-35 World Health Organization Regional Office for Europe, Copenhagen.
8. Kilbourne E.M., Perez-Rigau J.G., Heath C.W., et al. Clinical epidemiology of toxic oil syndrome: manifestations of a new illness. N Engl J Med. 309:1983;1408-1414.
9. Philen R.M., Posada M. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization Meeting Report. Sem Arthrit Rheum. 23:1993;104-124.
10. Abaitua Borda I., Philen R.M., Posada de la Paz M., et al. Toxic oil syndrome: thirteen-year mortality study. Int J Epidemiol. 27:1998;1057-1063.
11. Posada de la Paz M., Abaitua I., Terracini B., et al. Late deaths among young women affected by the toxic oil syndrome in Spain. [letter] Epidemiology. 10:1999;345.
12. Abaitua Borda I. Study on mortality. 7th revision. WP02A21. Presented at the 31st Scientific Committee for the Toxic Oil Syndrome Meeting. Copenhagen, May 14-15, 2002.
13. a revisión. Modificación clinica. vol. 1:1994;Ministerio de Sanidad y Consumo, Madrid.
14. Harris E.K., Albert A. Survivorship analysis for clinical studies. Owen D.B., Cornel R.G., Kenedy W.J., Kshirsagar A.M., Schilling E.G. Statistics, textbooks and monographs. vol. 114:1991;Marcel Dekker, New York.
15. Wang M.-C. Nonparametric estimation from cross-sectional survival data. J Am Stat Assoc. 86:1991;130-143.
16. Miller R.G. Jr. Survival analysis. 1981;John Willey & Sons, New York.
17. Belsey D.A. Conditioning diagnostics: collinearity and weak data in regression. 1991;John Wiley & Sons, New York.
18. Christensen E. Multivariate survival analysis using Cox's regression. Hepatology. 7:1987;1346-1358.
19. Gómez de la Cámara A., Posada de la Paz M., Abaitua Borda I., et al. Health status measurement in toxic oil syndrome. J Clin Epidemiol. 51:1998;867-873.
20. Toxic Epidemiology Study Group 1981. Toxic epidemic syndrome Spain. Lancet. 2:1982;697-702.
21. Posada de la Paz M., Owen D.B., Cornel R.G., Kenedy W.J., Kshirsagar A.M., Schiuing E.G. Late cases of toxic oil syndrome: evidence that the aetiologic agent persisted in oil stored for up to one year. Food Chem Toxicol. 27:1989;517-521.
22. Ladona M.G., Izquierdo-Martinez M., Posada de la Paz M., et al. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome. Environ Health Perspect. 109:2001;369-375.
23. Posada de la Paz M, Abaitua Borda I, Sánchez-Porro P, et al. A case series analysis of deaths in the TOS cohort: studies of risks factors and the validity of the cause of death certificates. Presented at the World Health Organization 26th meeting. Leuven, October 20-21, 1999.
24. Wohlfart J., Andersen P.K., Melbye M. Multivariate competing risks. Stat Med. 18:1999;1023-1030.
25. Lung M., Mc Neil D. Applying Cox regression to competing risks. Biometrics. 51:1995;524-532.
26. Gelpi E., Posada de la Paz M., Terracini B., et al. (WHO/CISAT Scientific Committee for the Toxic Oil Syndrome). The Spanish Toxic Oil Syndrome: epidemiological, immunological and toxicological knowledge twenty years after its occurrence. Environ Health Perspect. 110:2002;457-464.